0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-24H7799
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Global and Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size Status and Forecast 2021 2027

Global and Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-24H7799
Report
September 2021
99 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
SBMA, mainly manifested as systemic muscle atrophy, paralysis and systemic muscle bundle tremor, patients with systemic muscle weakness, especially the weakness of the two lower limbs to walk, tongue muscle atrophy is usually one of the main symptoms.
Market Analysis and Insights: Global Spinal and Bulbar Muscular Atrophy Treatment Market
The global Spinal and Bulbar Muscular Atrophy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal and Bulbar Muscular Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal and Bulbar Muscular Atrophy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal and Bulbar Muscular Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal and Bulbar Muscular Atrophy Treatment market.
Global Spinal and Bulbar Muscular Atrophy Treatment Scope and Market Size
Spinal and Bulbar Muscular Atrophy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal and Bulbar Muscular Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

5α-Reductase Inhibitors
Gonadotropin-releasing Hormone Agonists

Segment by Application

Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

AbbVie
Pfizer
GlaxoSmithKline
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 5α-Reductase Inhibitors
1.2.3 Gonadotropin-releasing Hormone Agonists
1.3 Market by Application
1.3.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Orthopedic Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Perspective (2016-2027)
2.2 Spinal and Bulbar Muscular Atrophy Treatment Growth Trends by Regions
2.2.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal and Bulbar Muscular Atrophy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Spinal and Bulbar Muscular Atrophy Treatment Industry Dynamic
2.3.1 Spinal and Bulbar Muscular Atrophy Treatment Market Trends
2.3.2 Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
2.3.3 Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
2.3.4 Spinal and Bulbar Muscular Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue
3.1.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue (2016-2021)
3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
3.4 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio
3.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
3.5 Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Type
4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027)
5 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Application
5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
6.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
6.2.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
6.2.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
6.2.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
6.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
6.3.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
6.3.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
6.3.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
6.4 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
6.4.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
6.4.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
7.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
7.2.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
7.3.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
7.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
7.4.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
9.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
9.2.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
9.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
9.3.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
9.4 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
9.4.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.1.4 AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.2.4 Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Century Pharmaceuticals
11.5.1 Century Pharmaceuticals Company Details
11.5.2 Century Pharmaceuticals Business Overview
11.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.5.4 Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.5.5 Century Pharmaceuticals Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.6.4 Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.6.5 Astellas Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.7.4 Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Boehringer Ingelheim International
11.8.1 Boehringer Ingelheim International Company Details
11.8.2 Boehringer Ingelheim International Business Overview
11.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.8.4 Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.8.5 Boehringer Ingelheim International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of 5α-Reductase Inhibitors
    Table 3. Key Players of Gonadotropin-releasing Hormone Agonists
    Table 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2016-2021)
    Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2022-2027)
    Table 10. Spinal and Bulbar Muscular Atrophy Treatment Market Trends
    Table 11. Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
    Table 12. Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
    Table 13. Spinal and Bulbar Muscular Atrophy Treatment Market Restraints
    Table 14. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2020)
    Table 17. Ranking of Global Top Spinal and Bulbar Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
    Table 21. Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 64. AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 65. AbbVie Recent Development
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 69. Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. GlaxoSmithKline Company Details
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 74. GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Development
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 79. Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. Century Pharmaceuticals Company Details
    Table 82. Century Pharmaceuticals Business Overview
    Table 83. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 84. Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 85. Century Pharmaceuticals Recent Development
    Table 86. Astellas Pharma Company Details
    Table 87. Astellas Pharma Business Overview
    Table 88. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 89. Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 90. Astellas Pharma Recent Development
    Table 91. Sanofi Company Details
    Table 92. Sanofi Business Overview
    Table 93. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 94. Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 95. Sanofi Recent Development
    Table 96. Boehringer Ingelheim International Company Details
    Table 97. Boehringer Ingelheim International Business Overview
    Table 98. Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 99. Boehringer Ingelheim International Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type: 2020 VS 2027
    Figure 2. 5α-Reductase Inhibitors Features
    Figure 3. Gonadotropin-releasing Hormone Agonists Features
    Figure 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Orthopedic Clinics Case Studies
    Figure 7. Ambulatory Surgical Centers Case Studies
    Figure 8. Spinal and Bulbar Muscular Atrophy Treatment Report Years Considered
    Figure 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players in 2020
    Figure 14. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
    Figure 16. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 20. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 21. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 22. United States Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2016-2027)
    Figure 38. China Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. AbbVie Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 58. Pfizer Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 61. Century Pharmaceuticals Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 62. Astellas Pharma Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 63. Sanofi Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 64. Boehringer Ingelheim International Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Deep Brain Stimulation Devices Market Insights and Forecast to 2028
Global Deep Brain Stimulation Devices Market Insights and Forecast to 2028

While Parkinsons Disease segment is altered to an CAGR throughout this forecast period.Global Deep Brain Stimulation Devices Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-22V9092
Fri Jan 07 00:00:00 UTC 2022

Add to Cart

Global Traumatic Brain Injury Diagnostic Market Size Status and Forecast 2022
Global Traumatic Brain Injury Diagnostic Market Size, Status and Forecast 2022

The global Traumatic Brain Injury Diagnostic market size is projected to reach US 1889.8 million by 2027 from US 838.9 million in 2020 at a CAGR of 12.7 during 20212027.Global Traumatic Brain Injury Diagnostic Market Size Status and Forecast 2022.

120 Pages
Type: Report
Code: QYRE-Auto-33S8930
Thu Jan 06 00:00:00 UTC 2022

Add to Cart

Global Neurology Software Market Size Status and Forecast 2022
Global Neurology Software Market Size, Status and Forecast 2022

The global Neurology Software market size is projected to reach US 961.2 million by 2027 from US 639.1 million in 2020 at a CAGR of 5.9 during 20212027.Global Neurology Software Market Size Status and Forecast 2022.

120 Pages
Type: Report
Code: QYRE-Auto-5H268
Thu Jan 06 00:00:00 UTC 2022

Add to Cart

Global Attention Deficit Hyperactivity Disorder ADHD Market Size Status and Forecast 2022
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Status and Forecast 2022

The global Attention Deficit Hyperactivity Disorder ADHD market size is projected to reach US 18060 million by 2027 from US 11480 million in 2020 at a CAGR of 6.7 during 20212027.Global Attention Deficit Hyperactivity Disorder ADHD Market Size Status and Forecast 2022.

120 Pages
Type: Report
Code: QYRE-Auto-14N9172
Thu Jan 06 00:00:00 UTC 2022

Add to Cart